These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1159 related articles for article (PubMed ID: 32600349)
1. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma. Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349 [TBL] [Abstract][Full Text] [Related]
2. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis. Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898 [TBL] [Abstract][Full Text] [Related]
3. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620 [TBL] [Abstract][Full Text] [Related]
4. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study. Yan L; Ren Y; Qian K; Kan X; Zhang H; Chen L; Liang B; Zheng C BMC Gastroenterol; 2021 Apr; 21(1):182. PubMed ID: 33879085 [TBL] [Abstract][Full Text] [Related]
5. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching. Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma. Endo K; Kuroda H; Oikawa T; Okada Y; Fujiwara Y; Abe T; Sato H; Sawara K; Takikawa Y Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723 [TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis. Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509 [TBL] [Abstract][Full Text] [Related]
8. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis. Yang Y; Yu H; Qi L; Liu C; Feng Y; Qi J; Li J; Zhu Q Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection. Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995 [TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study. Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with radiofrequency ablation versus DEB-TACE alone in Chinese hepatocellular carcinoma patients. Zhu D; Yuan D; Wang Z; Chen S Medicine (Baltimore); 2019 Jun; 98(26):e15682. PubMed ID: 31261491 [TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study. Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of combined therapy radiofrequency ablation/transarterial chemoembolization versus transarterial chemoembolization/radiofrequency ablation on management of hepatocellular carcinoma. El Dorry AK; Shaker MK; El-Fouly NF; Hussien A; El-Folly RF; El Fouly AH; Abd El Tawab K Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1573-1577. PubMed ID: 32796363 [TBL] [Abstract][Full Text] [Related]
14. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation. Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215 [TBL] [Abstract][Full Text] [Related]
15. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241 [TBL] [Abstract][Full Text] [Related]
16. Chemoembolization versus radiofrequency ablation for single small (≤ 3 cm) hepatocellular carcinoma: a propensity score matching analysis. Kim GH; Kim JH; Shim JH; Kim SY; Kim PH; Ko HK; Gwon DI; Shin JH; Lee SJ; Chu HH; Won HJ; Shin YM; Kim N Eur Radiol; 2024 Sep; 34(9):5517-5528. PubMed ID: 38329504 [TBL] [Abstract][Full Text] [Related]
17. The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization. Li L; Xin Y; Zhang X; Chen Y; Yang Y; Zhou X; Ye F Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101878. PubMed ID: 35151909 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation. Wang X; Liang H; Lu Z Minim Invasive Ther Allied Technol; 2020 Dec; 29(6):344-352. PubMed ID: 31375044 [No Abstract] [Full Text] [Related]
19. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome. Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment. Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]